Rectitude Holdings Announces $32.6 Million Standby Equity Purchase Agreement to Launch a Bitcoin Treasury Strategy
Globenewswire· 2025-09-08 20:00
SINGAPORE, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Rectitude Holdings Ltd. (Nasdaq: RECT; the “Company” or “Rectitude”), a Singapore-based provider of safety equipment and related industrial products, today announced that it is initiating a Bitcoin treasury strategy via entering into a Standby Equity Purchase Agreement (the “SEPA”) with Constantinople Limited, a British Virgin Islands Company led by Tian Jia, an experienced Bitcoin investor, as Lead Investor, and Chen Zhiqiang, former co-founder and CTO of Tron, ...
Mohist AI Limited Launches TranGPT, an AI Translation and TTS SaaS Platform Empowering Cross-Border Professionals
Globenewswire· 2025-09-08 19:56
The Hong Kong–based company introduces a multilingual AI-powered communication tool designed for e-commerce sellers, financial professionals, and global enterprises.Hong Kong, China, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Mohist AI Limited, a Hong Kong–registered technology company, today announced the official launch of TranGPT, a multilingual AI-powered translation and text-to-speech (TTS) Software-as-a-Service (SaaS) platform. Built for cross-border e-commerce, international finance, and global business, Tra ...
SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds
Globenewswire· 2025-09-08 19:54
SALT LAKE CITY, Utah, Sept. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics innovator specializing in biomedical applications of silicon nitride (Si₃N₄), today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 1,099,431 shares of common stock of the Company originally issued in February 2025, having an exercise price of $3.32 per share. The shares of ...
Alterity Therapeutics Raises A$20.0 million in Strategic Placement
Globenewswire· 2025-09-08 19:35
MELBOURNE, Australia and SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced it has received binding commitments for a capital raising of A$20.0 million (the “Placement”) of fully paid ordinary shares (“New Shares”) to International and Australian professional investors. "We are thankful for the continued inte ...
Sparton Resources Inc. Pense Critical Metals Project Exploration Permits Received
Globenewswire· 2025-09-08 19:30
New Massive Sulphide Mineralization FoundTORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Sparton Resources Inc. (TSXV-SRI) ("Sparton" or the "Company”) announced today that field operations are underway at the Pense Critical Metals Project near Englehart in Northern Ontario and Quebec. The Pense mineralization exhibits many similarities to the world-class Outokumpu deposits in Finland. Results of the initial drill program and Ontario Junior Exploration Program (“OJEP”) funding assistance at Pense on the Ontario ...
TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment
Globenewswire· 2025-09-08 19:30
Phase 3 trial to evaluate two subcutaneous BRIUMVI dosing regimensNEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has commenced in a Phase 3 trial evaluating subcutaneous BRIUMVI (ublituximab-xiiy), the company’s anti-CD20 monoclonal antibody, in people with relapsing forms of multiple sclerosis (RMS). BRIUMVI is currently approved in the United States, as well as several ex-US territories, as a one-hour intravenous (IV) infusion administere ...
PharmaCorp to Acquire a Pharmacy in Ontario for $5,300,000, New Non-Binding Letter of Intent to Acquire Two Pharmacies in Eastern Canada, Updates on Previously Announced Non-Binding Letters of Intent and Filing of Q2 Investor Presentation
Globenewswire· 2025-09-08 19:30
SASKATOON, Saskatchewan, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce the signing of a definitive share purchase agreement to acquire a 100% interest in a PharmaChoice Canada bannered pharmacy business located in Ontario (the “Acquisition”). This transaction marks PharmaCorp’s first acquisition under its charter company structure, which was established through the purchase completed on April 30, 2025. In addition, PharmaCorp ha ...
Humanoid Global Announces Strategic Investment in RideScan, a Pioneer Advancing AI for Robotics Safety and Performance
Globenewswire· 2025-09-08 19:30
– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES –Vancouver, BC & Edinburgh, Scotland, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to announce that it has made its first strategic software investment into RideScan Ltd ( ...
FTI Consulting Appoints Shaun Rangappa, MD, MSHA, as Chief Clinical Executive and Senior Managing Director in Healthcare Business Transformation Practice
Globenewswire· 2025-09-08 19:30
公司人事任命 - FTI咨询公司任命Shaun Rangappa博士为高级董事总经理 负责医疗保健业务转型业务 隶属公司金融与重组部门[1] - Rangappa博士将兼任医疗保健业务转型业务的首席临床执行官 支持公司在医生门诊服务 数字健康 收入周期管理 临床运营 劳动力管理等医疗行业服务[3] 高管专业背景 - Rangappa博士拥有弗吉尼亚大学医学院医学博士学位 具备超过30年医疗保健行业经验 涵盖临床实践 临床流程评估 绩效改进 技术赋能 治理 领导力和变革管理等领域[2] - 加入FTI咨询前曾在德勤咨询生命科学与医疗保健业务部门工作20年 主导过众多商业和联邦客户的大规模转型项目[5] 公司业务定位 - 医疗保健客户面临财务运营压力 领导层更替和医生职业倦怠等多重挑战[5] - Rangappa博士将就战略 运营 转型和劳动力挑战为医疗保健客户提供咨询 帮助应对行业持续变革[4] - 公司以提供敏捷且基于证据的解决方案著称 在引导客户应对变革方面具备特殊专长[6] 公司基本面 - 截至2025年6月30日 公司在全球32个国家和地区拥有7900名员工[6] - 2024财年公司实现营业收入37亿美元[6] - 公司是全球领先的专家服务公司 专注于为面临危机和转型的组织提供服务[6]
Composition of the shareholders’ nomination board of Harvia Plc
Globenewswire· 2025-09-08 19:30
Harvia Plc, Stock Exchange Release, September 8, 2025 at 2.30 PM EEST Composition of the shareholders’ nomination board of Harvia Plc Harvia Plc’s shareholders’ nomination board prepares proposals concerning the election and remuneration of the Board Members as well as the remuneration of the members of the various Board committees that will be submitted to future Annual General Meetings and to any Extraordinary General Meetings where necessary. The shareholders’ nomination board will be comprised of repres ...